摘要
[目的]研究康艾注射液对代偿期肝硬化患者Th1/Th2,Tc1/Tc2的影响。[方法]代偿期肝硬化患者60例,均按常规的抗病毒方案治疗24周后,30例(康艾注射液治疗组)再加用康艾注射液治疗2周;采用流式细胞仪检测所有患者治疗前、后Thl、Th2、Tcl、Tc2细胞的变化。[结果]康艾注射液治疗组、普通治疗组患者治疗后Th1、Th2及Tc1、Tc2均较治疗前明显下降,治疗后Th1/Th2和Tc1/Tc2比值均明显上升;康艾注射液治疗组治疗后Th1/Th2和Tc1/Tc2比值高于普通治疗组。[结论]康艾注射液可以促进Th1和Tc1应答,改善代偿期肝硬化患者Th1/Th2、Tc1/Tc2亚群的平衡。
[Objective]To investigate the changes of Thl/Th2 and Tcl/Tc2 pattern in patients with compensated cirrhosis treated by Kang＇ai injection. [Methods]By flow cytometry, we studied the Thl/Th2 and Tel/To2 pattern in patients with compensated cirrhosis before and after the treatment by Kang＇ai injection. I-Results]After the treatment, both groups showed significant de- crease in Thl, Th2 and Tel, Tc2. The ratio of Thl/Th2 and Tcl/Tc2 in both groups were in- creased significantly. Kang＇ ai rejection group has higher ratio than that of ordinary treatment group. [Conclusion]Kang＇ai injection can promote the Thl, Tcl response, regulate Thl/Th2 and Tcl/Te2 balance in patients with compensated cirrhosis.
出处
《中国中西医结合消化杂志》
CAS
2012年第5期197-200,共4页
Chinese Journal of Integrated Traditional and Western Medicine on Digestion
